MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information

Wouter Heyndrickx(Janssen (Belgium)), Hugo Ceulemans(Janssen (Belgium)), Friederike Zumsande(Amgen (Germany)), Arina Afanasyeva(Astellas Pharma (Japan)), Balázs Pejó(Budapest University of Technology and Economics), Christopher N. Luscombe(GlaxoSmithKline (Ireland)), Friedrich Rippmann(Merck KGaA, Darmstadt (Germany)), Martijn Oldenhof(KU Leuven), Lina Humbeck(Boehringer Ingelheim (Germany)), Ádám Arany(KU Leuven), Peter Ertl(TU Wien), Hideyoshi Fuji(Astellas Pharma (Japan)), Ansgar Schuffenhauer(Novartis (Switzerland)), Nicolas Do Huu, Peter Schmidtke, Péter Antal(Budapest University of Technology and Economics), Simon Harnqvist(University of York), Yves Moreau(KU Leuven), Darren V. S. Green(GlaxoSmithKline (Ireland)), Nicholas Holway(Novartis (Switzerland)), Gergely Ács(Budapest University of Technology and Economics), Jaak Simm(KU Leuven), Nicola Rieke, Shlok Verma(GlaxoSmithKline (Ireland)), Yax Sun(Amgen (United States)), Arnaud Gohier(Servier (France)), Adam Zalewski(Amgen (Germany)), Noé Sturm(Novartis (Switzerland)), Anastasia Pentina(Bayer (Germany)), Andreas H. Göller(Bayer (Germany)), Ritsuya Niwayama(Servier (France)), Ola Engkvist(AstraZeneca (Sweden)), Bernd Beck(Boehringer Ingelheim (Germany)), Nicolas Drizard, Stephen D. Pickett(GlaxoSmithKline (Ireland)), Régis Loeb(KU Leuven), Maria Teleńczuk, David Marcus(GlaxoSmithKline (Ireland)), Mathieu Galtier, Lewis Mervin(AstraZeneca (United Kingdom)), Rama Jabal, Lukas Friedrich(Merck KGaA, Darmstadt (Germany)), Michael Krug(Merck KGaA, Darmstadt (Germany)), Tobias Morawietz(Bayer (Germany)), Matthew Holmes(GlaxoSmithKline (Ireland)), Nikolas Fechner(Novartis (Switzerland)), Eric Boniface, Arne Dieckmann(Bayer (Germany))
Journal of Chemical Information and Modeling
August 29, 2023
Cited by 114


Related Papers